TB-500 vs BPC-157: What’s the Difference?
TB-500 and BPC-157 are the two peptides most associated with tissue and recovery research, and they come up together constantly — which is exactly why researchers ask how they actually differ. Both are studied in repair-related models, but they come from different origins and are studied through different mechanisms. Here’s the comparison.
What BPC-157 is studied for
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. Its research is heavily weighted toward gut and tissue models — tendon, ligament, and gastrointestinal repair endpoints. See specs and the COA on the BPC-157 product page.
What TB-500 is studied for
TB-500 is a synthetic version of a fragment of thymosin beta-4, a protein involved in cell migration and repair. Its research skews toward systemic tissue repair, flexibility, and recovery models. See the TB-500 product page.
TB-500 vs BPC-157: the core differences
- Origin: BPC-157 is derived from a gastric protein; TB-500 from thymosin beta-4.
- Research emphasis: BPC-157 → localised tendon/gut/tissue models; TB-500 → systemic cell-migration and recovery models.
- Mechanistic angle: different pathways, which is why they’re studied as complementary rather than interchangeable.
Why they’re so often paired
Because their research profiles are complementary — one localised, one systemic — the two are frequently studied together. That pairing is exactly what our Wolverine blend combines. For the practical side, see the BPC-157 + TB-500 stack guide.
Which should you choose?
It depends on the research model. Localised tendon or gut endpoints point toward BPC-157; systemic recovery endpoints toward TB-500; many protocols use both. Whichever you pick, we test every batch to 99%+ purity with a downloadable COA.
All products are sold strictly for laboratory and research use only. Not for human consumption.
Frequently asked questions
What is the difference between TB-500 and BPC-157?
BPC-157 is derived from a gastric protein and is studied mostly in localised tendon, gut, and tissue models; TB-500 is derived from thymosin beta-4 and is studied more in systemic cell-migration and recovery models.
Are TB-500 and BPC-157 used together?
Frequently — their complementary research profiles (localised vs systemic) are why they’re often paired, including in blends like Wolverine.
Are your TB-500 and BPC-157 third-party tested?
Yes — both are 99%+ purity by independent HPLC and mass spectrometry with a downloadable batch COA, shipped from Canadian stock.
